Product Information

MOMETASONE FUROATE 0.1% OINT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.3003 per GM under NDC 45802011937. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Mar 18, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MOMETASONE FUROATE 0.1% OINT

Mometasone Furoate
$0.3003per GM

Strength

1 mg/g

NDC

45802011937

Classification

Generic

Dosage Form

OINTMENT

Route

TOPICAL

Effective Date

10/21/2026

Active Ingredients

MOMETASONE FUROATE

Approval Type

Generic (ANDA)

FDA Application

ANDA076067

FDA Approved

3/18/2002

TE Code

AB

On Market Since

7/18/2008

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for MOMETASONE FUROATE 0.1% OINT has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 27.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3003 per GM
All-time high$0.6681 (Feb 12, 2014)
All-time low$0.2383 (Jan 22, 2020)
52-week high$0.3226
52-week low$0.2922
Median price$0.3314
Average price$0.3599
Largest weekly change+49.7% (Jan 22, 2014)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+2.8%

3M

+2.6%

6M

-4.8%

1Y

-2.8%

3Y

-12.1%

5Y

-22.1%

All

-27.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MOMETASONE FUROATE 0.1% OINT?

The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 0.1% OINT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.3003 per GM (NDC 45802011937), effective Nov 11, 2026.

How has the price of MOMETASONE FUROATE 0.1% OINT changed over time?

Over the history we have for it, the NADAC for MOMETASONE FUROATE 0.1% OINT has declined 27.5%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 0.1% OINT?

Since Nov 28, 2013, the NADAC for MOMETASONE FUROATE 0.1% OINT has ranged from a low of $0.2383 (Jan 22, 2020) to a high of $0.6681 (Feb 12, 2014), with a median of $0.3314 per GM.

Are there cheaper alternatives to MOMETASONE FUROATE 0.1% OINT?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MOMETASONE FUROATE 0.1% OINT, is $0.2072 per GM — about 31% below MOMETASONE FUROATE 0.1% OINT.

Who manufactures MOMETASONE FUROATE 0.1% OINT?

MOMETASONE FUROATE 0.1% OINT (NDC 45802011937) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.